☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
EMA
Averoa Receives the CHMP’s Positive Opinion for Xoanacyl to Treat Chronic Kidney Disease
April 2, 2025
Crinetics Pharmaceuticals Reports the EMA’s Acceptance of Paltusotine for Acromegaly
March 31, 2025
Merck Presents P-III (3475A-D77) Trial Data of SC Keytruda for NSCLC at ELCC 2025
March 28, 2025
Ionis Partners with Sobi for Olezarsen to Treat Familial Chylomicronemia Syndrome (FCS) & Severely Elevated Triglycerides
March 27, 2025
New Drug Designations - February 2025
March 25, 2025
Sanofi Reports the US FDA’s Acceptance & Priority Review of Tolebrutinib for Non-Relapsing Secondary Progressive Multiple Sclerosi...
March 25, 2025
Load more...
Back to Home
Modal title
×
Modal body text goes here.